Karnofsky Performance Status

"Karnofsky Performance Status" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A performance measure for rating the ability of a person to perform usual activities, evaluating a patient's progress after a therapeutic procedure, and determining a patient's suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy.

Descriptor ID	D017567
MeSH Number(s)	E05.318.308.980.438.475.456.500.500 N05.715.360.300.800.438.375.364.500.500 N06.850.520.308.980.438.475.364.500.500
Concept/Terms	Karnofsky Performance Status Karnofsky Performance Status Performance Status, Karnofsky Status, Karnofsky Performance Karnofsky Performance Status Scale Karnofsky Scale Scale, Karnofsky Karnofsky Index Index, Karnofsky

Below are MeSH descriptors whose meaning is more general than "Karnofsky Performance Status".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Data Collection [E05.318.308]
Surveys and Questionnaires [E05.318.308.980]
Health Surveys [E05.318.308.980.438]
Health Status Indicators [E05.318.308.980.438.475]
Patient Acuity [E05.318.308.980.438.475.456]
Severity of Illness Index [E05.318.308.980.438.475.456.500]
Karnofsky Performance Status [E05.318.308.980.438.475.456.500.500]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Data Collection [N05.715.360.300]
Surveys and Questionnaires [N05.715.360.300.800]
Health Surveys [N05.715.360.300.800.438]
Health Status Indicators [N05.715.360.300.800.438.375]
Patient Acuity [N05.715.360.300.800.438.375.364]
Severity of Illness Index [N05.715.360.300.800.438.375.364.500]
Karnofsky Performance Status [N05.715.360.300.800.438.375.364.500.500]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Data Collection [N06.850.520.308]
Surveys and Questionnaires [N06.850.520.308.980]
Health Surveys [N06.850.520.308.980.438]
Health Status Indicators [N06.850.520.308.980.438.475]
Patient Acuity [N06.850.520.308.980.438.475.364]
Severity of Illness Index [N06.850.520.308.980.438.475.364.500]
Karnofsky Performance Status [N06.850.520.308.980.438.475.364.500.500]

Below are MeSH descriptors whose meaning is related to "Karnofsky Performance Status".

Below are MeSH descriptors whose meaning is more specific than "Karnofsky Performance Status".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Karnofsky Performance Status" by people in this website by year, and whether "Karnofsky Performance Status" was a major or minor topic of these publications.

Bar chart showing 11 publications over 8 distinct years, with a maximum of 2 publications in 2015 and 2016 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2006	0	1	1
2008	0	1	1
2009	0	1	1
2015	0	2	2
2016	0	2	2
2018	1	0	1
2019	1	0	1
2020	0	2	2

Below are the most recent publications written about "Karnofsky Performance Status" by people in Profiles.

Avis NE, Levine B, Goyal N, Crawford SL, Hess R, Colvin A, Bromberger JT, Greendale GA. Health-related quality of life among breast cancer survivors and noncancer controls over 10?years: Pink SWAN. Cancer. 2020 05 15; 126(10):2296-2304.

View in: PubMed
Philip PA, Lacy J, Portales F, Sobrero A, Pazo-Cid R, Manzano Mozo JL, Kim EJ, Dowden S, Zakari A, Borg C, Terrebonne E, Rivera F, Sastre J, Bathini V, L?pez-Trabada D, Asselah J, Saif MW, Shiansong Li J, Ong TJ, Nydam T, Hammel P. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study. Lancet Gastroenterol Hepatol. 2020 03; 5(3):285-294.

View in: PubMed
Li S, Natwick T, Liu J, Morrison VA, Vidito S, Werther W, Yusuf AA, Usmani SZ. Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United States. J Geriatr Oncol. 2019 05; 10(3):490-496.

View in: PubMed
Dolgin NH, Smith AJ, Harrington SG, Movahedi B, Martins PNA, Bozorgzadeh A. Association Between Sarcopenia and Functional Status in Liver Transplant Patients. Exp Clin Transplant. 2019 10; 17(5):653-664.

View in: PubMed
Hartford AC, Davis TH, Buckey JC, Foote RL, Sinesi MS, Williams BB, Fariss AK, Schaner PE, Claus PL, Okuno SH, Hussey JR, Clarke RE. Hyperbaric Oxygen as Radiation Sensitizer for Locally Advanced Squamous Cell Carcinoma of the Oropharynx: A Phase 1 Dose-Escalation Study. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):481-486.

View in: PubMed
Caceres DH, Tob?n AM, Cleveland AA, Scheel CM, Berbesi DY, Ochoa J, Restrepo A, Brandt ME, Chiller T, G?mez BL. Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital. Am J Trop Med Hyg. 2016 Oct 05; 95(4):918-924.

View in: PubMed
D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, Freytes CO, Scott EC, Landau HJ, Moreb JS, Costa LJ, Ramanathan M, Callander NS, Kamble RT, Olsson RF, Ganguly S, Nishihori T, Kindwall-Keller TL, Wood WA, Mark TM, Hari P. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J Clin Oncol. 2015 Nov 10; 33(32):3741-9.

View in: PubMed
Liu Y, Alexander BM, Chen YH, Horvath MC, Aizer AA, Claus EB, Dunn IF, Golby AJ, Johnson MD, Friesen S, Mannarino EG, Wagar M, Hacker FL, Arvold ND. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases. J Neurooncol. 2015 Sep; 124(3):429-37.

View in: PubMed
Cohen LM, Ruthazer R, Germain MJ. Increasing hospice services for elderly patients maintained with hemodialysis. J Palliat Med. 2010 Jul; 13(7):847-54.

View in: PubMed
Moore KN, Frank SG, Alward EK, Landrum LM, Myers TK, Walker JL, Gold MA, McMeekin DS, Vesely SK, Mannel RS. Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer. 2009 Apr 01; 115(7):1472-80.

View in: PubMed

People

Explore

Similar Concepts

Top Journals